Horizon Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-440
| Closed | -$279K | – | 115 |
|
|
2025
Q1 | $279K | Sell |
440
-51
| -10% | -$32.3K | 0.05% | 80 |
|
|
2024
Q4 | $350K | Hold |
491
| – | – | 0.06% | 67 |
|
|
2024
Q3 | $516K | Hold |
491
| – | – | 0.1% | 44 |
|
|
2024
Q2 | $516K | Sell |
491
-15
| -3% | -$15.8K | 0.12% | 38 |
|
|
2024
Q1 | $487K | Buy |
506
+15
| +3% | +$14.4K | 0.13% | 43 |
|
|
2023
Q4 | $431K | Buy |
491
+5
| +1% | +$4.39K | 0.12% | 41 |
|
|
2023
Q3 | $400K | Hold |
486
| – | – | 0.16% | 42 |
|
|
2023
Q2 | $349K | Hold |
486
| – | – | 0.14% | 48 |
|
|
2023
Q1 | $399K | Sell |
486
-14
| -3% | -$11.5K | 0.3% | 37 |
|
|
2022
Q4 | $361K | Hold |
500
| – | – | 0.29% | 35 |
|
|
2022
Q3 | $344K | Hold |
500
| – | – | 0.25% | 36 |
|
|
2022
Q2 | $296K | Hold |
500
| – | – | 0.12% | 76 |
|
|
2022
Q1 | $349K | Hold |
500
| – | – | 0.11% | 73 |
|
|
2021
Q4 | $316K | Buy |
+500
| New | +$316K | 0.09% | 85 |
|